Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Biotricity, Inc.

Biotricity Reports Financial Results for Fiscal 2022 Fourth Quarter and Full Year
From Biotricity, Inc.
Via AccessWire
Tickers BTCY
Biotricity to Join Russell Microcap(R) Index
From Biotricity, Inc.
Via AccessWire
Tickers BTCY
Biotricity to Present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th
From Biotricity, Inc.
Via AccessWire
Tickers BTCY
Biotricity Issues Shareholder Update
From Biotricity, Inc.
Via AccessWire
Tickers BTCY
Biotricity to Launch Commercial Sales of Its Disruptive Cardiac Monitoring Device, Biotres in April 2022
From Biotricity, Inc.
Via AccessWire
Tickers BTCY
Biotricity Named to Fast Company's Annual List of the World's 50 Most Innovative Companies for 2022
From Biotricity, Inc.
Via AccessWire
Tickers BTCY
Biotricity, Inc. to Attend 34th Annual Roth Conference March 13th-15th
From Biotricity, Inc.
Via AccessWire
Tickers BTCY
Biotricity Now Taking Pre-Orders for its Biotres Wireless Wearable Cardiac Monitoring Device
From Biotricity, Inc.
Via AccessWire
Tickers BTCY
Biotricity Releases Fiscal 2022 Third Quarter Financial Results
From Biotricity, Inc.
Via AccessWire
Tickers BTCY
Biotricity to Report Third Quarter Fiscal 2022 Financial Results on February 14, 2022
From Biotricity, Inc.
Via AccessWire
Tickers BTCY
Biotricity Receives FDA 510(k) Clearance for its Biotres Cardiac Monitoring Device
From Biotricity, Inc.
Via AccessWire
Tickers BTCY
Biotricity Expands Distribution of New Bioheart Device on Amazon.com
From Biotricity, Inc.
Via AccessWire
Tickers BTCY
Biotricity Completes $12 Million Non-Dilutive Debt Financing
From Biotricity, Inc.
Via AccessWire
Tickers BTCY
Biotricity, a Leader in Remote Cardiac Health Monitoring Solutions, Issues Company Roadmap in 2021 Shareholder Letter
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers BTCY
Biotricity Delivers Bioheart, A Groundbreaking Consumer Heart Monitor
From Biotricity, Inc.
Via Business Wire
Tickers BTCY
Biotricity Releases Fiscal 2022 Second Quarter Financial Results
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers BTCY
Biotricity to Report Second Quarter Fiscal 2022 Financial Results on November 4, 2021
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers BTCY
Biotricity to Discuss its Breakthrough Patient Monitoring Solutions at Virtual LD Micro Main Event XIV on Oct. 13th
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers BTCY
Biotricity Launches Biocare Cardiac Application for Samsung's Galaxy Watch4 Series
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers BTCY
Remote Medical Diagnostic Company, Biotricity, to Ring the Nasdaq Stock Market Opening Bell on Thursday, October 7th
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers BTCY
Biotricity to Discuss its 2022 Strategic Outlook and Product Pipeline, at Benzinga Healthcare Small Cap Conference on Sept. 30
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers BTCY
Biotricity to Discuss Expansion of Remote Monitoring Medical Device Products at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 22nd
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers BTCY
Biotricity Unveils "Biokit" with 3 Personal Medical Devices to Expand into Cardiac Disease Management
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers BTCY
Biotricity Announces Closing of Exercise of Underwriter's Option to Purchase Additional Common Stock
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers BTCY
Biotricity to Discuss Sales Expansion, Recent Financing, and Wearable Medical Device Portfolio Expansion at H.C. Wainwright Conference
From Biotricity, Inc.
Via AccessWire
Tickers BTCY
Biotricity Completes Nasdaq Listing
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers BTCY
Biotricity Prices $15 Million Underwritten Public Offering of Common Stock and Listing on the Nasdaq Capital Market
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers BTCY
Biotricity Announces Proposed Underwritten Public Offering of Common Stock in Connection with Expected Nasdaq Listing
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers BTCY
Biotricity Reports 290% Revenue Growth Year Over Year in Record First Quarter
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers BTCY
Biotricity to Report First Quarter Fiscal 2022 Financial Results on August 16, 2021
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers BTCY
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.